X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The companies will jointly discover and optimize small molecule medicines against select therapeutic targets by combining their expertise in artificial intelligence, machine learning, computational chemistry and drug discovery to unlock difficult-to-drug targets.
Lead Product(s): Undisclosed
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Small molecule
Partner/Sponsor/Collaborator: Johnson & Johnson Innovative Medicine
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration April 04, 2024
Details:
The proceeds will support the advancement of multiple programs for clinical studies of immunology and oncology therapeutics & several of these molecules have the potential to enter the clinical development in next 12 months.
Lead Product(s): Undisclosed
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Ascenta Capital
Deal Size: $101.0 million Upfront Cash: Undisclosed
Deal Type: Series C Financing December 05, 2023
Details:
The proceeds will enable Odyssey to advance its portfolio of precision immunomodulators and oncology medicines in support of its mission of developing innovative medicines to treat serious human diseases.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Undisclosed
Partner/Sponsor/Collaborator: General Catalyst
Deal Size: $168.0 million Upfront Cash: Undisclosed
Deal Type: Series B Financing October 13, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
